These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 10218722

  • 1. Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia.
    Fogari R, Zoppi A, Corradi L, Preti P, Mugellini A, Lusardi P.
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):534-9. PubMed ID: 10218722
    [Abstract] [Full Text] [Related]

  • 2. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R, Zoppi A, Pasotti C, Poletti L, Tettamanti F, Malamani G, Corradi L.
    J Cardiovasc Pharmacol; 1989 Apr; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [Abstract] [Full Text] [Related]

  • 3. The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels.
    Fogari R, Zoppi A, Tettamanti F, Malamani G, Pasotti C.
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1287-90. PubMed ID: 1826213
    [Abstract] [Full Text] [Related]

  • 4. Beta-blocker effects on plasma lipids in antihypertensive therapy: importance of the duration of treatment and the lipid status before treatment.
    Fogari R, Zoppi A, Tettamanti F, Poletti L, Lazzari P, Pasotti C, Corradi L.
    J Cardiovasc Pharmacol; 1990 Jan; 16 Suppl 5():S76-80. PubMed ID: 11527140
    [Abstract] [Full Text] [Related]

  • 5. Effects of different beta-blockers on lipid metabolism in chronic therapy of hypertension.
    Fogari R, Zoppi A, Pasotti C, Poletti L, Tettamanti F, Maiwald C.
    Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):597-604. PubMed ID: 2905341
    [Abstract] [Full Text] [Related]

  • 6. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
    Sirtori CR, Johnson B, Vaccarino V, Montanari G, Cremoncini M, Gianfranceschi G, Sirtori M, Dujovne CA.
    Clin Pharmacol Ther; 1989 Jun; 45(6):617-26. PubMed ID: 2567218
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
    Fogari R, Zoppi A, Tettamanti F, Poletti L, Rizzardi G, Fiocchi G.
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1145-9. PubMed ID: 1982059
    [Abstract] [Full Text] [Related]

  • 8. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
    Silke B, Guy S, Riddell JG.
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
    [Abstract] [Full Text] [Related]

  • 9. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
    Bur A, Woisetschläger C, Herkner H, Derhaschnig U, Quehenberger P, Hirschl MM.
    Z Kardiol; 2002 Sep; 91(9):685-92. PubMed ID: 12448067
    [Abstract] [Full Text] [Related]

  • 10. Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients.
    Cicero AF, Veronesi M, Prandin MG, Di Gregori V, Ambrosioni E, Borghi C.
    Fundam Clin Pharmacol; 2009 Oct; 23(5):583-8. PubMed ID: 19555395
    [Abstract] [Full Text] [Related]

  • 11. Differentiation of beta-blocker effects on serum lipids and apolipoproteins in hypertensive patients with normolipidaemic or dyslipidaemic profiles.
    Vyssoulis GP, Karpanou EA, Pitsavos CE, Skoumas JN, Paleologos AA, Toutouzas PK.
    Eur Heart J; 1992 Nov; 13(11):1506-13. PubMed ID: 1361175
    [Abstract] [Full Text] [Related]

  • 12. A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients.
    Milne RJ, Vander Hoorn S, Jackson RT.
    Pharmacoeconomics; 1997 Sep; 12(3):384-408. PubMed ID: 10170463
    [Abstract] [Full Text] [Related]

  • 13. Dyslipidemic effects of cigarette smoking on beta-blocker-induced serum lipid changes in systemic hypertension.
    Vyssoulis GP, Karpanou EA, Pitsavos CE, Toutouza MA, Paleologos AA, Toutouzas PK.
    Am J Cardiol; 1991 May 01; 67(11):987-92. PubMed ID: 1673284
    [Abstract] [Full Text] [Related]

  • 14. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
    Grimm RH, Flack JM, Grandits GA, Elmer PJ, Neaton JD, Cutler JA, Lewis C, McDonald R, Schoenberger J, Stamler J.
    JAMA; 1991 May 01; 275(20):1549-56. PubMed ID: 8622245
    [Abstract] [Full Text] [Related]

  • 15. Effects of beta-blockers on the concentration and oxidizability of plasma lipids.
    Dimmitt SB, Williams PD, Croft KD, Beilin LJ.
    Clin Sci (Lond); 1998 Jun 01; 94(6):573-8. PubMed ID: 9854453
    [Abstract] [Full Text] [Related]

  • 16. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S, Simons LA, Hickie JB, Chang S.
    Artery; 1990 Jun 01; 17(2):60-70. PubMed ID: 1968740
    [Abstract] [Full Text] [Related]

  • 17. Influences of nonselective, beta(1)-selective and vasodilatory beta(1)-selective beta-blockers on arterial pulse wave velocity in normotensive subjects.
    Kahonen M, Ylitalo R, Koobi T, Turjanmaa V, Ylitalo P.
    Gen Pharmacol; 2000 Oct 01; 35(4):219-24. PubMed ID: 11827729
    [Abstract] [Full Text] [Related]

  • 18. Alterations in plasma lipids consequent to endurance training and beta-blockade.
    Morton AR, Stanforth PR, Freund BJ, Joyner MJ, Jilka SM, Hartzell AA, Ewy GA, Wilmore JH.
    Med Sci Sports Exerc; 1989 Jun 01; 21(3):288-92. PubMed ID: 2567483
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the effect of celiprolol and nifedipine on blood pressure and plasma lipids.
    van Hoof R, Desager JP, Harvengt C, Fagard R, Lijnen P, Peerenboom P, Staessen J, Thijs L, Van Mieghem W, Amery A.
    J Cardiovasc Pharmacol; 1992 Aug 01; 20(2):268-73. PubMed ID: 1381018
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension.
    D'Agostino RB, Kannel WB, Stepanians MN, D'Agostino LC.
    Am J Cardiol; 1993 Jan 01; 71(1):82-7. PubMed ID: 8093585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.